Login
Navigate Fool.com
Will CYTX beat
the market?
Community Rating: 2 Stars: Unattractive

2.34 -0.01 (-0.43%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.35
Previous Close $2.35
Daily Range $2.30 - $2.46
52-Week Range $2.00 - $3.93
Market Cap $176.5M
P/E Ratio -6.00
Dividend (Yield) $0.00 (0.0%)
Volume 215,247
Average Daily Volume 567,966
Current FY EPS -$0.35

How do you think CYTX
will perform against the market?

Top CYTX Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted July 30, 2011

Cytori is a very polarizing stock. Cheerleaders like Zacks point to positive data from clinical trials of adipose-derived regenerative cells in breast reconstruction, and a potential expansion of the … More

0 Replies Reply Report this Post
 

NeroSagetrade (< 20)
Submitted February 12, 2008

What a staggeringly STAGGERINGLY bad company! The numbers are absolutely obstrusive. These guys could write a book on how to lose money and it would be a best seller. Cytori has lost a whopping 52M in … More

1 Replies Reply Report this Post

News & Commentary

Fast and Furious Health Care Stocks This Week

MannKind, Cytori Therapeutics, and Omeros are among the health care stocks soaring this week.

Pre-Market Most Active for Nov 6, 2013 : MSPD, BP, BAC, TSLA, ALU, CYTX, ABX, FB, MSFT, NOK, ITMN,

Pre-Market Most Active for Nov 6, 2013 : MSPD, BP, BAC, TSLA, ALU, CYTX, ABX, FB, MSFT, NOK, ITMN, TLK

Four Big Healthy Biotech Gainers, One Big Loser

Why Cytori Shares Skyrocketed

Is this meaningful? Or just another movement?

Why Regeneron, Cytori, and Endo Could Climb Higher Today

Regeneron, Cytori, and Endo Health are well-poised to open higher today. Let’s take a look at the headlines moving these stocks.

Cytori Patents Adipose-Derived Cell Therapy for Cardiovascular Disease in Australia

Cytori Obtains Celution® System Approval in Singapore

Four Small-Cap Growth Names with Different Value Drivers: Keay Nakae

Four Small-Cap Growth Names with Different Value Drivers: Keay Nakae

Cytori Reports First Half and 2nd Quarter 2013 Business and Financial Results

See More CYTX News...

Sector

Healthcare

Industry

Drugs

Cytori Therapeutics, Inc. (USA) (CYTX) Description

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions. Website: http://www.cytori.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks